James McLaughlin | Chief Executive

Having studied Retail Management at Bournemouth University James began his career as Head of Sales at Southampton FC, despite being a lifelong Portsmouth fan!

During his four-and-a-half  stay with the Club, James was a key member of the management team that delivered the club’s new £32m St Mary’s Stadium, an FA Cup Final appearance and the highest league table position in the Premier League.

James moved to Holland as Product Manager for Football Equipment for Nike EMEA and continued his moved within football by joining Watford FC as Commercial Director with one of his key achievements being a 23,000 sold out Sir Elton John concert at Vicarage Road

With Watford securing promotion in 2006, James headed to Birmingham and joined Edgbaston Cricket Ground as Commercial Director and once again was part of the management team that saw the opening of the new look £32m Edgbaston in the summer of 2011. The move to the stadium saw Jaguar become a long term partner of the Club

After nearly six years at Warwickshire and having been a Trustee of Cure Leukaemia since 2010 James made the switch into the third sector becoming CEO of Cure Leukaemia in April 2012.

Supporting the work of the world class clinical team based at the internationally acclaimed Centre for Clinical Haematology, led by Professor Charlie Craddock CBE, Cure Leukaemia has continued to grow year on year.

James is now focussed on ensuring the sustainability of TAP for the future and continuing the steady growth of Cure Leukaemia.

He was also instrumental in securing the partnership with the Tour de France in the UK, aligning Cure Leukaemia with one of the world’s biggest and most famous annual sporting events.

James regularly takes part in sporting events including the Great Birmingham Run, New York Marathon, London 2 Paris and Copa Del CL. In 2024 James ran 224 miles in just over two weeks and raised over £100k which will fund two Cure Leukaemia Research Nurses.

How to help Cure Leukaemia?

Get Involved

Get this in your inbox - subscribe to our newsletter